Trials / Unknown
UnknownNCT04991909
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to assess the safety and tolerability of HRS4800 after multiple oral administration with different dose regimens in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS4800 | HRS4800 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2021-08-23
- Primary completion
- 2022-05-30
- Completion
- 2022-05-30
- First posted
- 2021-08-05
- Last updated
- 2021-08-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04991909. Inclusion in this directory is not an endorsement.